| Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering | 06/28 11:32 | globenewswire.com |
| SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients | 06/26 08:00 | globenewswire.com |
| Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering | 01/02 17:58 | globenewswire.com |
| Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering | 12/28 08:00 | globenewswire.com |
| Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study) | 12/27 09:00 | globenewswire.com |
| Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results | 11/09 16:05 | globenewswire.com |
| Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules | 08/25 08:00 | globenewswire.com |
| Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results | 08/16 07:00 | globenewswire.com |
| Bluejay Diagnostics Announces Reverse Stock Split | 07/21 07:00 | globenewswire.com |
| Why Is Bluejay Diagnostics (BJDX) Stock Up 17% Today? | 07/07 08:20 | investorplace.com |